Faecal microbiota transplantation for refractory C lostridium difficile infection

BMJ Case Rep. 2019 Nov 27;12(11):e231027. doi: 10.1136/bcr-2019-231027.

Abstract

Faecal microbiota transplantation (FMT) has become a part of the treatment algorithm for Clostridium difficile infection (CDI), particularly for recurrent infections when antibiotics have diminishing efficacy. Notably, despite a significant proportion of patients suffering from refractory disease, there is a general lack of evidence describing the use of FMT in this patient cohort. We present here a case of successful treatment of refractory CDI in a patient under critical care.

Keywords: adult intensive care; infection (gastroenterology); infectious diseases.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Clostridium Infections / therapy*
  • Fecal Microbiota Transplantation*
  • Female
  • Humans